Xarelto Litigation Updates

To date there have been 15,000 cases filed in the MDL. The first two trials will be held in the Eastern District of Louisiana. The first trial, The matter of Boudreaux, Joseph J. Jr., is scheduled to begin on April 24, 2017. The Plaintiff, Joseph Boudreaux was prescribed Xarelto to reduce the risk of stroke…

Taxotere Reference Guide

Having met with many Taxotere users over the last few months we have learned about a variety of treatments and products. It was recently suggested to us that we compile a referral list to share that would include local or online vendors of products such as hair pieces, wigs, temporary eyebrow tattoos, hair growth products…

XARELTO BLEEDING LAWSUITS

More than 15,000 claims against Janssen Pharmaceuticals have been filed by people who have had severe bleeding incidents after taking Xarelto, a popular blood-thinning drug. Risk of bleeding is the most serious side effect of all blood-thinning medication. Thousands of lawsuits accuse Bayer Healthcare and Janssen Pharmaceuticals, the makers of Xarelto, of not providing adequate…

NEW MDLs CERTIFIED

The U.S. Judicial Panel on Multidistrict Litigation has consolidated cases in Abilify, Talc and Taxotere suits among others. The Talc litigation has been transferred to New Jersey judge Freda Wolfson.  She currently presides over Chakalos v. Johnson & Johnson, filed in November 2014 making it the most advanced suit.  New Jersey is also the home…

FDA ISSUES WARNING ABOUT SERIOUS SIDE-EFFECTS ASSOCIATED WITH FLUROQUINOLONES OUTWEIGHING THE BENEFITS

Fluroquinolones are the most popular drugs to treat mild bacterial infections, but it was not until recently that their deadly side-effects were exposed. Over 33 million Americans have taken these antibiotics annually, and of these, the most popular is Levaquin, made by the company Johnson & Johnson. Many physicians were unaware of the side-effects of…